From: Health-related quality of life of COVID-19 two and 12 months after intensive care unit admission
All patients n = 94 | 12-month EQ-5D-3L Visual Analog Scale n = 82 | 12-month EQ-5D-3L Time trade-off n = 86 | 12-month mMRC dyspnea scale n = 86 | ||||
---|---|---|---|---|---|---|---|
Linear regression coefficient ± SD | p | Linear regression coefficient ± SD | p | Linear regression coefficient ± SD | p | ||
At two-month assessment | |||||||
mMRC dyspnea scale, median (IQR) | 1 (0–2) | − 2.39 ± 1.62 | 0.146 | − 0.06 ± 0.03 | 0.059 | 0.25 ± 0.09 | 0.012 |
EQ-5D-3L, Visual analog scale, median (IQR) | 70 (60–85) | 0.42 ± 0.10 | < 0.001 | 0.01 ± 0.00 | 0.001 | 0.05 ± 0.52 | 0.917 |
EQ-5D-3L, time trade-off, median (IQR) | 0.80 (0.36–0.91) | 15.29 ± 5.60 | 0.008 | 0.33 ± 0.10 | 0.002 | − 1.09 ± 0.33 | 0.002 |
Six-minute walk test, m, median (IQR) | 392 (322–484) | 0.01 ± 0.02 | 0.952 | 0.0004 ± 0.0004 | 0.326 | − 0.001 ± 0.001 | 0.459 |
Normalized six-minute walk test, %, median (IQR) | 58 (47–69) % | 0.09 ± 0.12 | 0.437 | 0.004 ± 0.002 | 0.092 | − 0.01 ± 0.01 | 0.171 |
Total lung capacitya, % of predicted, median (IQR) | 78 (63–89) | − 0.57 ± 0.12 | 0.632 | − 0.001 ± 0.007 | 0.872 | − 0.01 ± 0.01 | 0.175 |
Total lung capacitya < 80% of predicted, n (%) | 37 (47) | − 2.04 ± 3.86 | 0.599 | − 0.02 ± 0.07 | 0.799 | − 0.32 ± 0.23 | 0.04 |
Forced vital capacity, % of predicted, median (IQR) | 76 (67–93) | 0.02 ± 0.09 | 0.832 | 0.002 ± 0.002 | 0.901 | − 0.02 ± 0.01 | 0.114 |
Forced vital capacity, < 80% of predicted, n (%) | 39 (45) | 4.14 ± 3.59 | 0.253 | 0.02 ± 0.07 | 0.736 | − 0.47 ± 0.22 | 0.037 |
Forced expiratory volume in one second, % of predicted, median (IQR) | 77 (67–90) | 0.05 ± 0.09 | 0.572 | 0.001 ± 0.002 | 0.704 | − 0.01 ± 0.01 | 0.704 |
FEV1/FVC, %, median (IQR) | 83 (77–87) | 0.10 ± 0.19 | 0.598 | 0.001 ± 0.004 | 0.681 | − 0.02 ± 0.01 | 0.681 |
FEV1/FVC < 70%, n (%) | 9 (10) | − 6.31 ± 6.12 | 0.305 | − 0.05 ± 0.12 | 0.678 | − 0.05 ± 0.12 | 0.678 |
Diffusing capacity for carbon monoxideb, % of predicted, median (IQR) | 56 (45–67) | 0.08 ± 0.12 | 0.528 | 0.002 ± 0.002 | 0.433 | − 0.01 ± 0.01 | 0.433 |
Carbon monoxide transfer coefficientb, % of predicted, median (IQR) | 87 (76–96) | 0.11 ± 0.11 | 0.279 | 0.003 ± 0.002 | 0.158 | − 0.01 ± 0.01 | 0.158 |
Diffusing capacity for carbon monoxideb < 80% of predicted, n (%) | 54 (69) | − 0.23 ± 4.28 | 0.958 | − 0.01 ± 0.08 | 0.895 | 0.03 ± 0.26 | 0.895 |
Sniff nasal inspiratory pressurec, % of predicted, median (IQR) | 60 (43–82) | − 0.02 ± 0.07 | 0.818 | 0.002 ± 0.001 | 0.909 | − 0.002 ± 0.005 | 0.909 |
Maximal inspiratory pressured, % of predicted, median (IQR) | 78 (59–95) | − 0.04 ± 0.05 | 0.491 | 0.001 ± 0.001 | 0.523 | − 0.001 ± 0.004 | 0.523 |
Maximal inspiratory pressure < 80% of predicted, n (%) | 44 (56) | − 0.24 ± 3.71 | 0.949 | 0.05 ± 0.07 | 0.487 | − 0.05 ± 0.07 | 0.487 |
PaO2e, mmHg, median (IQR) | 91 (82–97) | 0.27 ± 0.18 | 0.140 | 0.00 6 ± 0.003 | 0.081 | − 0.03 ± 0.01 | 0.002 |
PaCO2e, mmHg, median (IQR) | 38 (35–40) | − 0.99 ± 0.53 | 0.065 | − 0.01 ± 0.01 | 0.248 | 0.06 ± 0.03 | 0.093 |
pHe, median (IQR) | 7.44 (7.42–7.46) | 70.33 ± 69.77 | 0.318 | − 0.15 ± 1.17 | 0.897 | − 4.35 ± 4.17 | 0.300 |
SaO2e, %, median (IQR) | 97 (96–98) | 2.79 ± 1.36 | 0.044 | 0.04 ± 0.02 | 0.105 | − 0.28 ± 0.08 | 0.001 |